Nature news
A brand-new brain imaging research study led by researchers at the Centre for Addiction and Mental Health (CAMH) has actually revealed what scientists refer to as the greatest proof up until now that long COVID is related to damage to dopamine-releasing nerve cells in the brain. Released in eBioMedicinethe findings might assist describe relentless issues such as fatigue-related loss of inspiration, slower motion, and memory problems. They might likewise point towards brand-new treatment methods.
Long COVID is approximated to impact about 5 percent of the international population, consisting of approximately 2 million individuals in Canada. The condition can include a broad series of signs that continue for a minimum of 3 months after the preliminary COVID-19 infection. Typical brain-related signs consist of tiredness, brain fog, memory issues, and low state of mind. Regardless of how prevalent and disruptive long COVID can be, there are presently no evidence-based treatments, in part due to the fact that researchers still do not totally comprehend what is occurring in the brain.
Brain Scans Reveal Changes in the Dopamine System
For the brand-new research study, scientists utilized positron emission tomography (PET), an imaging method that can determine biological activity inside the brain. They analyzed a reputable marker related to the health and stability of dopamine nerve cells in individuals with long COVID and compared the outcomes with those from healthy individuals.
The scientists discovered significantly lower levels of this marker in individuals with long COVID throughout all significant locations of the striatum. The striatum is a group of brain areas that assists control inspiration, motion, and thinking. Lower marker levels recommend a minimized density of dopamine nerve terminals.
Various patterns of marker loss were likewise connected with various signs. Lower levels in the forward striatum were connected to higher loss of inspiration. Decreases in the dorsal putamen were connected with slower motion, while lower levels in the caudate putamen were gotten in touch with memory troubles.
“Our findings provide compelling evidence that long COVID involves the loss of dopamine-releasing neurons,” states Dr. Jeffrey Meyer, Senior Scientist at the Brain Health Imaging Centre, Canada Research Chair, and senior author of the research study. “This kind of injury is well known to produce symptoms like lack of motivation and motor slowing, and may contribute to memory difficulties in other neurological conditions. Our results suggest a similar process is occurring in long COVID.”
Earlier Research Pointed to Brain Inflammation
The brand-new findings develop on previous work by the very same research study group revealing that individuals with long COVID have uncommonly high levels of swelling in the brain. That swelling seemed specifically noticable in areas including great deals of dopamine-releasing nerve cells.
“We know that inflammation can injure dopamine neurons. While our earlier research showed high levels of inflammation in those regions, this study provides direct evidence that the dopamine neuron marker is reduced in the same regions — and that this loss correlates with patients’ symptoms,” discusses Dr. Meyer.
Taken together, the 2 research studies recommend a possible connection in between consistent brain swelling and damage including the dopamine system.
A New Direction for Long COVID Treatment
The outcomes might alter how scientists approach the biology and treatment of long COVID. Much of the previous research study has actually fixated swelling in the brain and modifications in immune activity. By contrast, extremely couple of medical trials have actually focused straight on dopamine-releasing nerve cells.
“These results indicate that long COVID is, at least in part, a disorder of the brain’s dopamine system,” includes Dr. Meyer. “This suggests that repurposing medications that augment the function of dopamine-releasing neurons, including dopamine precursors and inhibitors of dopamine metabolism, could be a promising approach.”
For individuals coping with long COVID, the findings might likewise offer a biological description for signs that can be tough to determine from the exterior.
“For five years I have been seeking answers on what happened to me after I contracted COVID in 2021,” states Susan Deuville, lived experience research study consultant to Dr. Meyer. “It was a crushing loss of the life I had and the person I was before. The research of Dr. Meyer brings hope. It also validates what long COVID sufferers have always known — long COVID is real and the effects are devastating.”
Medical Trial Planned to Target Dopamine Function
Structure on these outcomes, the scientists prepare to start a medical trial in the upcoming number of months that will target dopamine function in individuals with long COVID. The objective will be to figure out whether customizing dopamine activity can enhance memory, inspiration, and tiredness.
The trial will be performed in cooperation with University Health Network (UHN), as part of a collaboration in between the medical facilities focused on bridging the space in between psychological and physical healthcare.
The research study was supported by the Canadian Institutes of Health Research (CIHR).
Find out more
Discover more from PMN S.P.O.R.T.S - A PRIME MEDIA NETWORK BRAND
Subscribe to get the latest posts sent to your email.
